The China’s market for In Vitro Fertilization (IVF) for Health Managers

Professional highlights of the IVF market in China 2024. A significant demographic challenge that China’s leaders face: the country’s plummeting fertility rate. Here’s a summary of the issue:

China’s Fertility Crisis

• Fertility Rate: The Total Fertility Rate (TFR) in China has fallen to 1.1 children per woman, which is well below the replacement level of 2.1 needed to maintain a stable population.
• Population Decline: As a consequence of this low fertility rate, China’s population declined for the second consecutive year in 2023.
• Historical Context: This decline is not solely a result of the one-child policy (enforced from 1980 to 2016), which restricted urban families mostly to one child and rural families to two. The decrease in fertility began in the 1970s due to factors like urbanization, education improvements for women, and a shift away from Mao-era pro-natalist policies.
• Regional Comparison: The situation in China mirrors broader regional trends in East Asia, where countries like Japan and South Korea have also seen dramatic drops in their fertility rates, with South Korea’s TFR catastrophically below 0.8.

Seven Trends About Fertility Problems in China:

1. Aging Population: The low fertility rate has accelerated the aging of China’s population, creating potential economic and social challenges, such as a shrinking workforce and increased healthcare costs.
2. Urbanization Impact: Increased urbanization has been linked to lower fertility rates, as living costs in cities are higher and there is more access to education and employment opportunities for women.
3. Female Educational Attainment: Higher levels of education among women often correlate with delayed childbearing and reduced number of children, significantly influencing the fertility rate.
4. Economic Factors: Economic uncertainty and the rising cost of living, including the high cost of child-rearing, deter young couples from having more children.
5. Policy Changes: Despite the end of the one-child policy and the introduction of incentives for larger families, these measures have so far not significantly reversed the declining fertility trend.
6. Cultural Shifts: There is a cultural shift towards smaller family norms, and young adults are prioritizing career and personal freedom over starting families.
7. Health and Lifestyle: Modern health and lifestyle changes have also contributed to lower fertility rates, including factors like increased stress levels and higher rates of conditions that may affect fertility.

These trends underline a complex crisis that not only affects China but is evident across many developed East Asian economies. The situation calls for comprehensive policy planning and innovative solutions to mitigate the long-term impacts of an aging and declining population.

Nowadays IVF services are booming in China. According to some industry estimates sites by NIKKEI ASIAN REVIEW, Chinese couples spend around $8 billion each year on IVF. Of that, in accordance with figures cited in China’s state-linked media, over $1 billion is spent outside of China. In addition to this, the future of the IVF industry seems to be promising. The well-known website Bloomberg stated that the reproductive health market in China has a potential value of 15$ billion!

Why is the demand for In Vitro Fertilization growing?

China has finally abolished its one-child policy. However, the paradox has appeared among Chinese women, who are struggling to get pregnant these days. Why does it happen? These fertility problems are caused by different factors: higher stress levels accompanying economic development; the high level of pollution in the country; late marriage; late childbirth; smoking and alcohol use.

In Vitro Fertilization industry in China: a great opportunity for foreign companies

Only 460 mainland hospitals were licensed for IVF in April 2019.

Moreover, couples need to spend approximately 20,000 -30,000 RMB per IVF cycle, while for ICSI it is 25,000 to 35,000 RMB per cycle. And, since fertility service treatment is not covered by public or private insurance, assisted reproductive technology remains out of reach for many infertile couples in China.

Therefore, tapping into this increasing demand of IVF services in China has become a significant opportunity for foreign companies to leverage this market.

Why are the Chinese looking for In Vitro Fertilization services abroad?

“Excess of demand for IVF treatment, limited clinics available and months in waiting for consultation appointments” are among the main factors driving Chinese women to seek programs abroad. Chinese people prefer going abroad to look for high quality IVF treatments and because it is usually cheaper to do the treatments abroad.

Moreover, many Chinese couples can choose the gender of the future baby abroad, which is one of the crucial points.

The IVF market is highly competitive in China

Currently, the highest quality providers of IVF services come from abroad but the fast-growing demand from Chinese singles and couples is the key to foreign hospitals and clinics’ success on the Mainland. Foreign Clinics providing IVF services in China are at a competitive advantage in both high-quality healthcare services and diversity of supplied procedures.

IVF Reflects China’s Strategic Public Health Initiative

The Chinese government’s strategic decision to significantly expand IVF (In Vitro Fertilization) facilities across the country by 2025 demonstrates a proactive response to the rising demand for fertility treatments. Currently, China conducts over half a million IVF cycles each year, which result in approximately 300,000 births. This initiative not only underscores China’s commitment to addressing its demographic challenges but also represents a significant growth opportunity within the reproductive health services market. The enhancement of IVF facilities is expected to greatly support families wishing to increase their size, signaling a promising development for market stakeholders.

What is Influencing the IVF Industry in China?

1. Growing Demand for Donor Egg Treatments: Amidst broader IVF services, there’s a rising preference for donor egg treatments, reflecting diverse fertility needs and the challenges of later-in-life pregnancies.
2. Adoption of Disposable IVF Devices: The IVF sector is witnessing a shift towards disposable devices, driven by their convenience and the imperative to meet stringent standards for infection control, enhancing both safety and efficiency in fertility clinics.
3. Dominance of ICSI Procedures: Intracytoplasmic Sperm Injection (ICSI), a specialized form of IVF, is gaining prominence. This technique is particularly effective in treating male infertility, offering hope to many families and potentially increasing the procedure’s adoption rate.
4. Fertility Clinics as Key Market Players: Fertility clinics are increasingly becoming the primary care providers for IVF treatments, thanks to their specialized care capabilities and the availability of advanced treatments, aligning with patient expectations for high-quality reproductive healthcare.

IVF Business Implications and Opportunities

For businesses operating within the IVF sector, these developments offer multiple avenues for growth. Marketing strategies should focus on educating potential users about the safety, effectiveness, and accessibility of IVF treatments. Additionally, partnerships with healthcare providers and alignment with government health initiatives could enhance service delivery and market penetration. Finally, leveraging digital platforms to raise awareness and facilitate discussions around fertility challenges can help destigmatize IVF treatments and broaden their acceptance among the Chinese population.

IVF tourism in China: Women traveling abroad for a baby

Demand for IVF in China has surged since the one-child policy was scrapped, but unmarried women are denied access. SBS News follows one hopeful mother on her international journey to start a family.

How can your IVF clinic attract Chinese customers?

The crucial point is to get the attention of potential clients. In China, your company means nothing if you don’t have instruments such as E-Reputation, a quality Chinese website, and a strong online presence in Chinese social media. Chinese are tending to do lots of research before they choose any services especially when it comes to Healthcare.

Read below to know how to succeed in the IVF market.

IVF Clinics need to work on e-reputation

You need to start building your e-Reputation in China, simply due to the reason that English content, positive reviews in western media platforms are not be visible on the Chinese net.

Mandarin Chinese Characters are use in the vast majority of internet research (over 97,5%). Also, Chinese web is a unique ecosystem that requires a fresh and creative approach.

You should forget big western players such as Facebook, Google, and Twitter, cause instead of it all China has WeChat, Baidu, Weibo, and many others. To approach this whole set of new platforms, the Chinese specific way in terms of Mandarin communications, content, and engagement should be taken into consideration.

Choosing the right strategy to Promote an IVF Clinic in China

To build your E-reputation in China, you should be strategic with your content. Introduce your services has high-quality services, as the reference of the market. Remember that you are promoting a costly service abroad, thus, it must be worth the price. Medical tourism is doing great with Chinese citizens, but only the clinics can prove they are the best to make money.

Earn the trust of Chinese Women Looking for IVF

If foreign clinics have a better reputation than most Chinese, this won’t be enough to appeals to medical tourists. Localize your content but keep your identity to have a unique selling point.

Forget about “passive” business model

Chinese healthcare market is mostly lead by Foreign healthcare companies especially in terms of IVF services. Most of them were using a “passive” business model that consists in creating partnership with tour agents.

In other words, foreign healthcare companies are taking the lead in providing IVF services in China by adopting a “passive” business model, which is driven by partnerships with tour agents and referral offices.

However, nowadays the rules have been changed since IVF treatments services market is a “tidbit” for Foreign clinics. Therefore, you will need to act smart and fast to enter the Chinese market without wasting your time.

Use Baidu to promote your IVF Clinic in China

One of the effective strategies to reach the Chinese market is advertising through search engines. Among these search engines, we have Baidu, which is by far the most powerful leader in the Chinese search engine market, with nearly 80% market share.

There are several other search engines equally powerful, but none is comparable to Baidu in terms of market shares.

Just like Google, Baidu offers a wide variety of advertising options for businesses. However, advertising on it requires that companies drown in a ton of administrative paperwork, which is incredibly difficult for non-Chinese companies. Baidu needs a large amount of information to stay in line with Chinese government regulations.

Baidu SEO is crucial for a foreign clinic in China

SEO on Baidu is the key for the visibility of your business, since it is the most used search engine in China and it ranks 5th among the most visited sites in the world. But not only! Baidu is Key to build a strong reputation. The more results there are about your clinic on Baidu, the more trustable you are.

Baidu has more than 800 million web pages and offers a wide range of services, such as web searches, image and music searches, forums and Q&A service. SEO on Baidu requires several steps, which are different from what needs to be done on Google.

 

Baidu SEO a long term solution for foreign IVF Clinic

The notions of trust and notoriety remain essential for companies wishing to enter the Chinese market and be visible on Baidu. Key SEO strategies include keyword optimization, backlinks, and content sharing, this is the way to generate quality traffic.

Compared with SEA, SEO takes more time, but it is a long-term solution in terms of developing a better e-reputation and is more stable. The quality search results won’t disappear after you stop the campaign, on the contrary, you will remain higher in the rankings and continue to drive traffic.

Optimize your IVF Clinic presence on chinese social media

In China, there are around 1 billion internet users and 91% of Chinese online users have a social media account, in comparison with US where around 67% of online population have one.

The standard Chinese internet user follows an average of eight brands and over 38% of Chinese netizens make purchasing choices based on social media recommendations. As reported by Ogilvy, over 55% of Chinese users had participated in online discussions about brands and that discussions are able to directly affect businesses.

Wechat marketing

• Wechat Brochure
• Services Account
• Group Marketing
• “Newsletter”
• Mini program
• CRM
• Ads

There is much you can do on Wechat. The app, just like Baidu is crucial in earning the trust of potential Chinese customers. If Wechat is not a great app to build a following, it is a great place to nurture your existing following, a little bit like an email list would be in the west.

RED aka Little Red Book: An unsuspectedly great app to promote IVF Clinic

Why is this a great app for IVF clinics you’ll ask me? Well, very simple, the app user base is mainly composed of women (millennials) from wealthy Chinese cities. The app is a to-go for reviews and testimonials in the high-end beauty and health sector. Motherhood is a non-negligeable segment of RED.

RED is good to gain a following and to engage with it. It is an excellent place to work with KOLs and to build your E-reputation through “shopping notes”.

Chinese Forums and Q&A

Although there is a big demand for IVF in China, many are clueless about their options and what exactly IVF means. Use Q&A & Forums to educate peoples on the topic with useful content (and promote your clinic in a subtle way).

But also, create dialogue, and have peoples expressing themselves about your services as a clinic. Forums and Q&A topic tends to rank well on Chinese search engines and participate actively in building your brand awareness.

Case Study: The international medical center EMC entered the Chinese market

The European Medical Center (EMC), a well-known multIdisciplinary clinic based in Moscow, chose to act a multi-channel marketing strategy to enter the Chinese market due to the greater trust of Chinese patients in foreign healthcare.

Thanks to our support EMC has a chinese website and is present on two of the most popular social networks in China: Weibo and Wechat. It also could rank on 1st page for “famous reproductive clinic in Russia” on Baidu

To conclude on Promoting IFV Clinic in China

an increasing number of chinese women are seeking for fertility treatments. The demand and utilization of these are continually growing, but the barriers are still too high. China isn’t ready to offer a sufficient answer to this huge demand for service yet.

So, in order to fill this gap, foreign companies that can offer fertility treatments, such as IVF or ART, should start building a digital strategy to enter China.

And you’re considering promoting your IVF Clinic in China?

If you have any questions, don’t hesitate to contact us.

Our dedicated team can offer a healthcare plan for China’s Online strategy. We know how to promote your business in China using numerous digital tools, such as E-PR, Media Buying (DSP) & Community Management, Baidu SEO, and SEM.

Read more about:

• Why it’s crucial to use Baidu’s SEO for your business in China?—Update 2020
• WeChat Advertising 2020 Guide
• Vitamins and Dietary Supplements Market in China 2020 Update

Now I have enough data to write the article. Let me produce the full Gutenberg HTML block.

The 2026 market reality: what the data shows

China’s IVF market was valued at US$5.77 billion in 2024 and is forecast to reach US$11.26 billion by 2033, growing at a CAGR of 7.72%, according to a 2025 GlobeNewswire research report. The infertility rate among Chinese couples now stands at 18.2%, up from 11.9% in 2007, according to China Briefing. Only 1.3 million IVF cycles are performed annually, while an estimated 8.1 million women need treatment. That gap between demand and capacity defines the opportunity for health managers and foreign brands entering this space.

Who the health manager is, and why the role exists

In China’s fertility clinics, the “health manager” (健康管理师) sits between the doctor and the patient. This role did not exist in most public hospitals ten years ago. It was created to handle the volume. Public hospitals account for 86% of all IVF services in China, according to China Briefing. That concentration creates bottlenecks. Doctors at top-tier hospitals in Beijing and Shanghai see dozens of patients per day. There is no time for diet counseling, emotional support, or appointment coordination.

The health manager fills that gap. Their responsibilities typically include: tracking treatment cycles, coordinating between departments (reproductive endocrinology, genetics, radiology), advising on lifestyle factors before embryo transfer, and following up after each procedure. In private clinics and premium hospital wards, this role now extends to digital communication. Most health managers use WeChat to maintain daily contact with patients. They send medication reminders, share lab results, and answer questions at hours when clinics are closed.

WeChat’s role in this process is structural, not optional. A Microsoft Research study on WeChat in Chinese hospitals found that clinic staff use the platform to give patients access to medical insights, appointment scheduling, and ongoing support outside of consultation hours. For IVF patients, who go through multi-week treatment cycles with strict timing requirements, this kind of continuous contact is not a convenience. It directly affects outcomes.

The health manager role is now becoming a certification. China’s Ministry of Human Resources and Social Security formally recognizes the health manager qualification (健康管理师三级/二级). Training programs have expanded in cities like Chengdu, Wuhan, and Guangzhou. Fertility clinics, particularly private ones, now list certified health managers as a competitive differentiator in their marketing materials. Foreign healthcare brands entering China need to understand this role because their Chinese partners will expect it, and their patients will ask about it.

How insurance reform changed patient behavior

Before 2023, most IVF patients in China paid entirely out of pocket. A single IVF cycle costs between 30,000 and 150,000 yuan depending on the clinic, the city, and the number of attempts. That price range put treatment out of reach for many couples outside major urban centers.

The policy shift came fast. Beijing added IVF and other assisted reproductive technologies (ART) to its basic medical insurance in July 2023. Within nine months, over 32,000 patients had been treated under the scheme, with RMB 190 million reimbursed, according to China Briefing. By early 2024, more than 1.03 million patients across 27 provinces had benefited from some form of ART insurance coverage, according to Xinhua.

Chongqing formalized 13 specific ART services under insurance as of January 1, 2025. Jingmen in Hubei Province introduced direct subsidies of up to 10,000 yuan for IVF procedures, effective January 1, 2026, according to Global Times. These are not symbolic gestures. They change who enters the clinic and when.

Insurance coverage changes patient behavior in a specific way: it lowers the decision threshold. Couples who previously waited, hoping to conceive naturally for two or three years, now start the IVF process earlier. That means more first-time patients, more patients with less medical literacy, and more demand for guidance before, during, and after treatment. This is exactly where health managers earn their value. The influx of newly insured patients is not a background trend. It is the primary driver of demand for structured patient management services in 2025 and 2026.

United Family Healthcare (UFH), which operates reproductive medicine centers in Beijing and other cities, is one example of a foreign-affiliated provider that built a structured patient coordination model early. Their IVF centers pair clinical staff with dedicated patient navigators who guide couples through each stage of the process. This model is now being copied by domestic private clinic groups across tier-one and tier-two cities.

What changed between 2024 and 2026

Three shifts define the 2024-2026 period for China’s IVF and health management market.

First, insurance access moved from pilot to national standard. In 2024, all 31 provincial-level regions had included some ART services under medical insurance. By early 2026, the question is no longer whether insurance covers IVF, but how much it covers and which procedures qualify. The focus has shifted from access to affordability optimization, which creates a specific advisory need that health managers are positioned to fill.

Second, the supply of clinics expanded but not enough. China had 539 IVF-licensed facilities in 2024. The National Health Commission set a target of one facility per 2.3 million people by 2025, which would require over 600 facilities. That target was not fully met. As of early 2026, the country still faces a geographic imbalance: top-tier clinics in Beijing, Shanghai, and Guangzhou are oversubscribed, while rural provinces remain underserved. Patients from smaller cities travel long distances for treatment, which increases the need for remote health management and digital coordination tools.

Third, the role of digital platforms in fertility care became formal. WeChat mini programs now handle appointment booking, cycle tracking, and post-transfer follow-up in major clinic networks. Xiaohongshu (Little Red Book) has become a primary channel where patients research clinics, share experiences, and ask questions. Clinics now actively manage their presence on this platform. For foreign brands offering fertility-related products or services, Xiaohongshu is where patient trust is built before the clinic visit.

Frequently asked questions

How much does IVF cost in China in 2025 and 2026?

A single IVF cycle in China costs between 30,000 and 150,000 yuan depending on the clinic type (public vs. private), the city, the treatment protocol, and the number of embryo transfer attempts. At public hospitals, basic protocols are at the lower end of this range. Private clinics in Shanghai or Beijing charge significantly more, especially for add-on services like preimplantation genetic testing (PGT). Insurance now covers at least 50% of costs in most provinces, but medication costs, diagnostic tests, and multiple cycles can still add up quickly. Subsidies in cities like Jingmen (up to 10,000 yuan for IVF as of January 2026) help but do not eliminate the financial burden for most families. Couples should ask their health manager or patient coordinator to map out the total projected cost across two to three cycles before starting.

What does a health manager do in a Chinese IVF clinic?

A health manager in a Chinese fertility clinic coordinates care across the full treatment journey. This includes scheduling consultations and procedures, tracking hormone levels and cycle timing, advising on nutrition and lifestyle before embryo transfer, and providing emotional support throughout the process. In practice, the health manager is the primary point of contact for patients, often more accessible than the treating physician. Communication happens largely through WeChat, where the health manager sends daily reminders, shares test results, and answers questions outside of clinic hours. In private clinics and premium hospital wards, health managers hold formal qualifications recognized by China’s Ministry of Human Resources and Social Security. The quality of health management at a clinic is increasingly a factor patients cite when choosing where to receive treatment.

Is IVF covered by insurance in China?

Yes, in most of China. All 31 provincial-level regions included some assisted reproductive technology (ART) services under basic medical insurance by 2024. Coverage varies by province in terms of which procedures are included and what percentage is reimbursed, but the national direction is clear: the government wants more couples to access IVF and is using insurance as the tool. Beijing was among the first major cities to act, adding IVF to its insurance program in July 2023. By early 2024, over 1.03 million patients had benefited nationally. In addition to insurance, some cities offer direct cash subsidies. Chongqing included 13 specific ART procedures under insurance from January 2025. The practical advice for patients is to verify their specific coverage with their clinic’s administrative team or health manager before starting treatment, as reimbursement rates and qualifying procedures differ across regions.

How is Xiaohongshu used in China’s fertility and IVF market?

Xiaohongshu (Little Red Book) is the primary platform where Chinese women research IVF clinics, share treatment experiences, and ask for recommendations. A typical patient journey starts on Xiaohongshu before the first clinic visit. Users post about their cycle results, medication side effects, embryo transfer outcomes, and hospital experiences in detail. Fertility clinics, health managers, and reproductive medicine specialists now maintain active accounts on the platform to answer questions and build credibility. For foreign brands selling fertility-related products (supplements, diagnostic tools, wellness services), Xiaohongshu is the most direct channel to reach patients before and during treatment. Content that performs well tends to be personal, specific, and educational, not promotional. A post explaining how to read a hormone test result will outperform a product advertisement by a wide margin.

How to move forward

If you are a foreign brand in the fertility, wellness, or medical device space targeting China’s IVF market, the entry points are specific. Start with platform presence. Xiaohongshu is where patients research. Build content that addresses real questions: clinic selection, treatment protocols, insurance navigation, lifestyle preparation. This is where trust is built. Work with a Xiaohongshu agency that understands healthcare content and can navigate the platform’s content policies around medical claims.

Second, connect with the health manager ecosystem. These professionals are the gatekeepers for product recommendations inside clinics. Brands that have built relationships with certified health managers and provided credible educational materials see higher uptake than those relying on traditional medical rep models alone.

Third, consider search visibility on Baidu. Patients in tier-two and tier-three cities search for IVF clinics, treatment costs, and insurance coverage information online before committing. A Baidu advertising strategy targeting high-intent keywords in this space can drive qualified inquiries from cities where clinic options are limited and patients are actively looking for information.

The market is growing quickly and the regulatory environment is supportive. The brands that will win are those that build credibility with patients and health professionals now, before the market becomes crowded. Contact our team at seoagencychina.com/contact-us to discuss your entry strategy.

Marcus Zhan is a China marketing specialist based in Shanghai. He covers digital marketing, consumer trends, and brand strategy for the Chinese market. Connect with him on LinkedIn for China health and fertility market insights.

Sources: GlobeNewswire, China IVF Market Report (February 2025) | https://www.globenewswire.com/news-release/2025/02/20/3029880/28124/en/China-s-In-Vitro-Fertilization-Market-Projected-to-Reach-US-11-26-Billion-by-2033-2025-Research-Report.html | China Briefing, China’s Fertility Services Market | https://www.china-briefing.com/news/chinas-fertility-services-market-growth-challenges-and-opportunities/ | Xinhua, China expands health insurance coverage of fertility treatment (May 2024) | https://english.news.cn/20240531/3bbb9f59aa3c4ffc95672f7d5eb37292/c.html | Global Times, Jingmen subsidy program (December 2025) | https://www.globaltimes.cn/page/202512/1350223.shtml | Microsoft Research, WeChat in Hospital (2020) | https://www.microsoft.com/en-us/research/wp-content/uploads/2020/03/WeChat-in-Hospital.pdf